Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Alfredo A. Santillan-Gomez"'
Autor:
Daniel Katselnik, Yanli Ding, Camilo Jimenez, Michael A. Liss, Bernadette Biondi, Zi Ming Cheng, Tobias Else, Marta Barontini, Nelly Burnichon, Rory Clifton-Bligh, Gustavo Armaiz-Pena, Alfredo A. Santillan-Gomez, Andrea Alvarez-Eslava, Deepa Vincent, Oksana Hamidi, Mio Kitano, Trisha Dwight, Enrique Maldonado, Joel E. Michalek, Diana E. Benn, Emmanuel Esquivel, Gabriela Sanso, Anne Paule Gimenez-Roqueplo, Maureen Koops, Art S. Tischler, Patricia L. M. Dahia, Xhingyu Zhang, Lauren Fishbein, Natalie Poullard, Anusha Vaidyanathan, Qianqian Liu, Shahida K. Flores, Neil Aronin, Ron Lechan, Elizabeth Bowhay-Carnes, Sara Ahmadi, Jan M. Bruder, Sarimar Agosto Salgado
Publikováno v:
J Clin Endocrinol Metab
Purpose This work aimed to evaluate genotype-phenotype associations in individuals carrying germline variants of transmembrane protein 127 gene (TMEM127), a poorly known gene that confers susceptibility to pheochromocytoma (PHEO) and paraganglioma (P
Publikováno v:
Cureus
Inflammatory myofibroblastic tumors (IMTs) are rare tumors that have been described only in a few cases in the literature. IMTs are mesenchymal neoplasms that typically affect children and young adults. The most common anatomical locations are the ab
Autor:
Alfredo A. Santillan-Gomez, Samar A. Jasser, Jeffrey N. Myers, Maher N. Younes, Seungwon Kim, Mei Zhao, David Fooshee, Fernando Gomez-Rivera
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 13(15 Pt 1)
Purpose: Anaplastic thyroid cancer (ATC) is a locally aggressive type of thyroid tumor with high rate of distant metastases. With conventional treatment, the median survival ranges from 4 to 12 months; therefore, new treatment options are needed. AZD
Autor:
Amelie G. Ramirez, Kipling J. Gallion, Alfredo A. Santillan-Gomez, Edgar Munoz, Amanda Sintes-Yallen
Publikováno v:
Cancer Epidemiology, Biomarkers & Prevention. 24:B12-B12
For Latina women, breast cancer is the leading cancer and we expect this trend to continue as the US Hispanic population expands. Latinas generally have lower survival rates for most cancers, even after accounting for differences in age and stage dis